An update on PARP inhibitors for the treatment of cancer
Sarah Benafif, Marcia Hall Mount Vernon Cancer Centre, Northwood, Middlesex, UK Abstract: The development of poly (adenosine diphosphate [ADP]) ribose polymerase (PARP) inhibitors (PARPi) has progressed greatly over the last few years and has shown encouraging results in the BRCA1/2 mutation&n...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-02-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/an-update-on-parp-inhibitors-for-the-treatment-of-cancer-peer-reviewed-article-OTT |